Search
Can Fite Biopharma Ltd
CANFAdd to Watchlist
2.130USD
-0.052-2.38%
Market hours 10/05, 11:43（ET）
4.56MMarket Cap
LossP/E TTM
Can Fite Biopharma Ltd (CANF) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Can Fite Biopharma Ltd in the past month.
--
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
50.000USD+2191.48%
CANF Analyst Recommendation Trends
In the current month, CANF has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CANF average Analyst price target in the last month is 50.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
1
1
1
1
2
3
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
2
2
2
2
3
CANF Analyst Rating for Peer Comparison
Updated: Oct 4, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Eli Lilly and Co
LLY
10
18
3
1
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.14
-1.43
-0.51
-0.55
-0.29
Actual
--
--
--
--
--
Surprise
--
--
--
--
--
FAQs
What is Can Fite Biopharma Ltd's price target?
Analysts forecast that Can Fite Biopharma Ltd's price target is USD 50.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 50.00.